Evaxion Biotech AS (EVAX)
0.919
+0.03
(+3.25%)
USD |
NASDAQ |
Dec 20, 16:00
0.9018
-0.02
(-1.87%)
After-Hours: 20:00
Evaxion Biotech Market Cap: 5.391M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk AS | 377.51B |
| Ascendis Pharma AS | 8.142B |
| DBV Technologies SA | 65.45M |
| Adaptimmune Therapeutics PLC | 154.76M |
| Akari Therapeutics PLC | 24.02M |
Market Cap Related Metrics
| PS Ratio | 1.273 |
| Price to Book Value | 72.85 |
| Price | 0.919 |
| Earnings Yield | -304.7% |